InstrumentpanelPortföljerBevakningslistaGemenskapUpptäckSkärm
NOT FOR DISTRIBUTION

Concentrix Corporation

NasdaqGS:CNXC Aktierapport

Börsvärde: US$1.7b

  • Översikt över företaget
    • Värdering
    • Framtida tillväxt
    • Tidigare resultat
    • Finansiell hälsa
    • Utdelning
  • Förvaltning
  • Ägarskap
  • Övrig information
  • Aktiegemenskap

Concentrix Balansräkning Hälsa

Finansiell hälsa kriterier kontrolleras 1/6

Concentrix har ett totalt eget kapital på $2.7B och en total skuld på $4.6B vilket ger sin skuldsättningsgrad till 169.7%. Dess totala tillgångar och totala skulder är $10.5B respektive $7.8B. Concentrix s EBIT är $620.7M vilket gör dess räntetäckningsgrad 2.2. Den har kontanter och kortsiktiga investeringar på $255.6M.

Viktig information

169.73%

Skuldsättning i förhållande till eget kapital

US$4.58b

Skuld

Räntetäckningsgrad2.2x
KontanterUS$255.57m
Eget kapitalUS$2.70b
Summa skulderUS$7.81b
Totala tillgångarUS$10.51b

Nya uppdateringar om finansiell hälsa

Inga uppdateringar

Recent updates

Seeking Alpha • Sep 18

Concentrix: This AI Bargain Stock Could Be The Ultimate Value Trap - Strong Sell

Summary Concentrix appears deeply undervalued on adjusted free cash flow metrics relative to its sub-$2 billion market cap, but I think its valuations are a trap. Despite attractive valuation, CNXC’s AI initiatives may be cannibalizing its traditional revenue streams, complicating the investment case. Recent financials suggest CNXC’s AI-driven cost reductions could undermine its own growth prospects. I remain bearish, as the company’s strategic shift raises concerns about long-term revenue sustainability. Read the full article on Seeking Alpha
User avatar
Uppdatering av berättelse • Sep 17

CNXC: Guidance Reset And Risk Expansion Will Shape Earnings Path Forward

Concentrix now carries an updated analyst fair value estimate of $30.00, up from $26.00, with analysts pointing to revised long term assumptions on revenue growth and profit margins following recent price target resets in the $26 to $45 range. Analyst Commentary Recent Street research on Concentrix shows a clear tilt toward more cautious expectations, with several bearish analysts trimming price targets after the latest fiscal Q2 report.
User avatar
Uppdatering av berättelse • Jul 21

CNXC: Guidance Reset And Investigation Will Shape Earnings Trajectory

For Concentrix, the analyst fair value estimate has been reduced from $54.00 to $26.00. Analysts cited softer revenue assumptions, higher discount rates, and updated earnings forecasts following fiscal Q2 results and revised guidance.
User avatar
Uppdatering av berättelse • Jul 07

CNXC: Reset Expectations And Index Shift Will Support Future Upside Potential

Analysts have lowered the Concentrix fair value estimate from $41.25 to $35.25, reflecting reduced long term revenue growth assumptions. Profit margin expectations and the future P/E input also shift in response to updated models following recent Q2 results and guidance.
User avatar
Uppdatering av berättelse • Jun 23

CNXC: Margin Resilience And Index Shift Will Support Repriced Upside Potential

Analysts have trimmed their price targets on Concentrix by $12 to $25, citing updated assessments of the company’s outlook while keeping key assumptions such as fair value at $41.25 and long term revenue growth and profit margin broadly unchanged. Analyst Commentary Recent research on Concentrix points to a more cautious stance on valuation, with several firms trimming price targets while keeping long term growth and margin assumptions broadly intact.
User avatar
Uppdatering av berättelse • Jun 07

CNXC: Margin Expansion And Buybacks Will Support Repriced Upside Potential

Analysts have reduced their price targets on Concentrix by $12 to $25, citing updated views on the company’s outlook. They maintained their fair value estimates and kept key model inputs such as discount rate, revenue growth, profit margin, and future P/E broadly unchanged.
User avatar
Uppdatering av berättelse • May 13

CNXC: Margin Resilience And Buybacks Will Support Repriced Upside Potential

Concentrix's analyst price target has been revised lower by a combined $24 to $25 across several firms, with analysts citing updated views on valuation and business outlook to support the adjustment. Analyst Commentary Across the latest research updates, analysts reduced their price targets for Concentrix by amounts ranging from $12 to $25, pointing to reassessments of valuation and the business outlook.
User avatar
Uppdatering av berättelse • Apr 25

CNXC: Margin Resilience And Buybacks Will Support Future Upside Potential

Analysts have trimmed their Concentrix price targets by $12 to $25, citing more conservative assumptions around future P/E multiples, while keeping fair value, discount rate, and margin expectations broadly unchanged. Analyst Commentary Bullish Takeaways Bullish analysts appear to see the P/E reset as a way to align expectations more closely with current sentiment, which can reduce the risk of overpaying for near term execution.
User avatar
Uppdatering av berättelse • Apr 10

CNXC: Higher Margin Outlook And Buybacks Will Support Future Upside Potential

Narrative Update The updated analyst price target for Concentrix moves from approximately $48.60 to about $41.25. This reflects recent cuts from several firms as analysts point to more measured revenue growth assumptions, offset by slightly higher projected profit margins and a lower future P/E multiple.
User avatar
Uppdatering av berättelse • Mar 27

CNXC: Higher Margin Outlook And Buybacks Will Support Future Undervalued Entry

The analyst price target for Concentrix has shifted from $62.20 to $48.60. Analysts attribute this change to updated assumptions around slower revenue growth, a higher profit margin profile, and a lower future P/E multiple following recent target cuts from Barrington, Baird, and Canaccord.
User avatar
Uppdatering av berättelse • Mar 12

CNXC: AI Rollout And Buybacks Will Support Future Undervalued Entry

Analysts have trimmed their price target on Concentrix by $4, reflecting updated views captured in recent research while keeping key fair value and growth assumptions essentially unchanged. Analyst Commentary Recent research around the $4 reduction in the price target highlights a mix of confidence in Concentrix’s core thesis and a more cautious stance on execution and risk.
User avatar
Uppdatering av berättelse • Feb 26

CNXC: Higher Discount Rate Assumptions Will Support Future Undervalued Entry

Analysts have trimmed their price target on Concentrix by $4, reflecting updated assumptions around discount rates and valuation multiples, while keeping fair value estimates for the business broadly unchanged. Analyst Commentary Analysts describe the $4 price target cut as a fine tuning of their models rather than a reset of their overall view on Concentrix, with fair value estimates broadly intact.
Analysartikel • Feb 16

Benign Growth For Concentrix Corporation (NASDAQ:CNXC) Underpins Stock's 30% Plummet

Concentrix Corporation ( NASDAQ:CNXC ) shareholders won't be pleased to see that the share price has had a very rough...
User avatar
Uppdatering av berättelse • Feb 12

CNXC: Updated Discount Rate Assumptions Will Support Future Undervalued Entry

Analysts have lowered their price target on Concentrix by $4, citing updated assumptions around discount rates and profitability, while keeping fair value estimates broadly stable. Analyst Commentary Analysts describe the recent US$4 reduction in the price target as a fine tuning of their view, reflecting updated discount rate assumptions and a more cautious stance on profitability, rather than a fundamental reset of Concentrix's underlying worth.
User avatar
Uppdatering av berättelse • Jan 29

CNXC: Updated Discount Rate And P/E Assumptions Will Support Future Undervalued Entry

Narrative Update on Concentrix Analysts have trimmed their price target on Concentrix by $4, citing updated assumptions around discount rates and future P/E expectations, while keeping their fair value estimate unchanged at $62.20. Analyst Commentary Recent research around Concentrix reflects a mixed tone, with the $4 trim to the price target tied mainly to updated discount rate inputs and revised P/E assumptions rather than a reset of the underlying fair value, which remains at $62.20.
User avatar
Uppdatering av berättelse • Jan 15

CNXC: Higher Discount Rate Reset Will Support Future Undervalued Entry Thesis

Analysts have trimmed their price target on Concentrix by about $2.63, citing updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E following recent research that included a $4 reduction highlighted at Baird. Analyst Commentary Analysts framing the new price target are trying to line up their fair value work with updated assumptions on discount rates, revenue growth, margins and the future P/E they think the market is willing to pay for Concentrix.
Analysartikel • Nov 08

Concentrix Corporation (NASDAQ:CNXC) Not Doing Enough For Some Investors As Its Shares Slump 28%

The Concentrix Corporation ( NASDAQ:CNXC ) share price has fared very poorly over the last month, falling by a...
Analysartikel • Sep 29

Concentrix's (NASDAQ:CNXC) Upcoming Dividend Will Be Larger Than Last Year's

The board of Concentrix Corporation ( NASDAQ:CNXC ) has announced that it will be paying its dividend of $0.36 on the...
User avatar
Uppdatering av berättelse • Sep 27

AI Integration And Webhelp Synergies Will Transform Business

Concentrix's consensus price target was modestly reduced to $64.83 as analysts factor in compressed valuation multiples from AI-related investor uncertainty and secular headwinds—rather than fundamental weakness—while maintaining confidence in growth reacceleration and strong business fundamentals. Analyst Commentary Compressed valuation multiples attributed to investor uncertainty over the impact of artificial intelligence on labor-intensive business models and broader secular headwinds, not due to fundamental company weakness.
Analysartikel • Apr 03

Concentrix Corporation's (NASDAQ:CNXC) Shares Leap 26% Yet They're Still Not Telling The Full Story

The Concentrix Corporation ( NASDAQ:CNXC ) share price has done very well over the last month, posting an excellent...
Analysartikel • Jan 29

The Market Lifts Concentrix Corporation (NASDAQ:CNXC) Shares 25% But It Can Do More

Concentrix Corporation ( NASDAQ:CNXC ) shareholders have had their patience rewarded with a 25% share price jump in the...
Seeking Alpha • Jan 17

Concentrix: Better Than Expected Results, GenAI, And Cheap

Summary Concentrix Corporation delivered better-than-expected EPS and revenue, driven by significant investments in its GenAI product suite and a booming AI customer experience market. The AI in customer experience market is projected to grow at a 22% CAGR, potentially boosting CNXC's future revenue and free cash flow growth. Despite risks from high debt levels and potential global tariffs, CNXC's substantial headcount growth and consistent net income make it appear undervalued. My financial model suggests CNXC is significantly undervalued, with an equity valuation of $6.5 billion and a target price of $102 per share. Read the full article on Seeking Alpha
Seeking Alpha • Dec 21

AI: Will Freshworks Leave Room For Concentrix?

Summary A.I. is revolutionising Customer Relationship Management (CRM), with Salesforce leading the market, leveraging Big Data to enhance customer interactions and sales conversions. Generative A.I. significantly boosts Customer Experience (CX) performance, with early adopters seeing a 25% increase in CX satisfaction, and the global CX market projected to grow to $33bn by 2030. Concentrix, with a $2.86bn market cap, offers comprehensive CX services including call centres. Freshworks is a SAAS only CX provider. Both companies have seen 70% plus share price declines, but one is still priced for growth, the other for business declines. Is this justified? Read the full article on Seeking Alpha

Analys av finansiell ställning

Kortfristiga skulder: CNXC s kortfristiga tillgångar ( $3.0B ) överstiger dess kortfristiga skulder ( $2.6B ).

Långfristiga skulder: CNXC s kortfristiga tillgångar ( $3.0B ) täcker inte dess långfristiga skulder ( $5.2B ).


Skuld till eget kapital Historik och analys

Skuldnivå: CNXC s nettoskuld i förhållande till eget kapital ( 160.3% ) anses vara hög.

Minska skulden: CNXC s skuldsättningsgrad har ökat från 37.9% till 169.7% under de senaste 5 åren.

Skuldtäckning: CNXC s skuld är inte väl täckt av operativt kassaflöde ( 16.2% ).

Räntetäckning: CNXC s räntebetalningar på sin skuld är inte väl täckta av EBIT ( 2.2 x täckning).


Balansräkning


Upptäck friska företag

7D

1Y

7D

1Y

7D

1Y

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/09/21 10:18
Aktiekurs vid dagens slut2026/09/18 00:00
Intäkter2026/05/31
Årlig intjäning2025/11/30

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
  • SEC Form 10-K
  • SEC Form 10-Q
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
  • Rapporter från analytiker
  • Blue Matrix
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
  • ICE Marknadsdata
  • SEC Form S-1
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
  • SEC Formulär 4
  • SEC Formulär 13D
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
  • SEC Form 10-K
  • SEC Form DEF 14A
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden
  • SEC Formulär 8-K

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.

Lär dig mer om det som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Concentrix Corporation bevakas av 5 analytiker. 3 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
David KoningBaird
Vincent ColicchioBarrington Research Associates, Inc.
Ruplu BhattacharyaBofA Global Research

Ta bättre investeringsbeslut var som helst

Skanna för att ladda ner
Öppna App StoreÖppna Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Visa datakällor
Marknader
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investeringsidéer
  • Undervärderade bolag
  • Starka utdelningar
  • Insiderköp
  • Kärnenergi
  • Autonoma fordon
  • Artificiell intelligens
  • Krypto och blockkedja
  • Cybersäkerhet
  • Fler idéer
Lager Gemenskaperna
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Funktioner och verktyg
  • Portföljspårning
  • Aktieskärm och varningar
  • Berättelser & rättvisa värden
  • Kalkylator för utdelning
Nyheter & Upptäckter
  • Senaste lagernyheter
  • Global Market Insights
  • Foxhole-forumet
  • Investeringsidéer
  • Gemenskapens berättelser
  • Vad är nytt
Simply Wall St
  • Planer och priser
  • Annonsering
  • Om oss
  • Kontakta oss
  • Karriär
  • Hjälpcenter
  • Lär dig investera i aktier
  • Affiliate-program
  • Affärer & företag
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Villkor och anvisningar
  • Integritetspolicy
  • AI-villkor
  • Guide för finansiella tjänster